(Total Views: 666)
Posted On: 08/20/2020 4:54:04 AM
Post# of 155161
After Several Months of Providing Requested Information About Manufacturing and Safety of Leronlimab, U.K.’s MHRA Accepts CytoDyn’s Request to Enroll in its Current Phase 3 Trial for COVID-19 Patients with Severe-to-Critical Symptoms
(0)
(0)
